Skip to search formSkip to main contentSkip to account menu

terizidone

Known as: 4,4'-(p-phenylenebis(methyleneimino))bis-3-isoxazolidone, terazolidone 
A broad spectrum antibiotic used as a second-line antitubercular drug, effective against pulmonary and extrapulmonary tuberculosis. Terizidone has… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Pirfenidone is a broad-spectrum antifibrotic medicine. In 2014, it was approved for the treatment of the idiopathic pulmonary… 
2018
2018
A chromatographic method has been developed and validated for the first time for analysis of terizidone in plasma. Terizidone was… 
2017
2017
The role of so-called “group 5” second-line drugs as a part of antibiotic therapy for multidrug-resistant tuberculosis (MDR-TB… 
2016
2016
Two simple, precise, rapid, accurate and economical spectrophotometric methods have been developed for the estimation of… 
2014
2014
Detection of drug-resistant tuberculosis (DR-TB) increases each year in South Africa (SA). Most cases result from airborne… 
2012
2012
A 43 year old male patient, known case of multidrug resistant tuberculosis, was prescribed antitubercular drugs: kanamycin…